Panfacial Botulinum Toxin Improves Patient Retention
February 2007 | Volume 6 | Issue 2 | 131 | Copyright © February 2007
Martin Braun MD
Abstract
The injection of botulinum toxin (Botox®, Allergan, Irvine, CA) is the most common cosmetic procedure in the US.
In the past 5 years, its use has climbed over 388%. In 2005, business development managers from Allergan audited 1,695
patient charts from the top 54 cosmetic practices in Canada. Despite the increasing popularity of this nonsurgical treatment,
on average only 57% of patients return for a second injection within 6 months. In the author’s clinical practice
92% of patients return for a second injection in this time frame. This paper will examine various factors that appear to
result in satisfied patients with a high retention rate. This article will show that panfacial botulinum toxin injected in
multiple sites with appropriate dosing improves patient retention. 
